Medlab Clinical ( (AU:MDC) ) just unveiled an announcement.
Medlab Clinical Limited announced the results of its 2023 Annual General Meeting, where key resolutions were voted on by shareholders. The meeting concluded with the approval of the remuneration report and the election of directors Edmond Tan, Tim Walker, and Joshua Light. Additionally, the appointment of MNSA as the auditor was confirmed, indicating shareholder support for the company’s current leadership and financial oversight.
More about Medlab Clinical
Medlab Clinical Limited operates in the biotechnology and pharmaceutical industry, focusing primarily on the development and commercialization of novel drug delivery platforms and pharmaceutical products. The company aims to improve patient outcomes through innovative treatments, particularly in the areas of pain management and chronic diseases.
Average Trading Volume: 10,000
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $9.9M
See more data about MDC stock on TipRanks’ Stock Analysis page.